Wolverine Trading, LLC Biomarin Pharmaceutical Inc Put Options Transaction History

Wolverine Trading, LLC

  • $94.2 Billion
  • Q2 2024

Put Options

25 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2024

May 15, 2024
BUY
$83.81 - $99.0 $1.09 Million - $1.29 Million
13,000 New
13,000 $1.14 Million
Q3 2023

Nov 15, 2023
SELL
$85.07 - $94.48 $1.21 Million - $1.34 Million
-14,200 Reduced 64.84%
7,700 $681,000
Q2 2023

Aug 23, 2023
BUY
$86.68 - $100.3 $1.01 Million - $1.16 Million
11,600 Added 112.62%
21,900 $1.9 Million
Q1 2023

May 15, 2023
SELL
$87.74 - $117.27 $754,564 - $1.01 Million
-8,600 Reduced 45.5%
10,300 $981,000
Q4 2022

Feb 14, 2023
BUY
$80.93 - $108.63 $526,045 - $706,095
6,500 Added 52.42%
18,900 $1.96 Million
Q3 2022

Nov 14, 2022
SELL
$82.16 - $96.94 $295,776 - $348,984
-3,600 Reduced 22.5%
12,400 $1.06 Million
Q2 2022

Aug 15, 2022
BUY
$71.48 - $86.85 $328,808 - $399,510
4,600 Added 40.35%
16,000 $1.34 Million
Q1 2022

May 16, 2022
SELL
$74.28 - $92.69 $475,392 - $593,216
-6,400 Reduced 35.96%
11,400 $888,000
Q4 2021

Feb 14, 2022
SELL
$71.72 - $91.47 $1.22 Million - $1.55 Million
-17,000 Reduced 48.85%
17,800 $1.59 Million
Q3 2021

Nov 12, 2021
SELL
$74.77 - $85.47 $299,080 - $341,880
-4,000 Reduced 10.31%
34,800 $2.67 Million
Q2 2021

Aug 06, 2021
BUY
$75.51 - $84.79 $460,611 - $517,219
6,100 Added 18.65%
38,800 $3.24 Million
Q1 2021

May 14, 2021
SELL
$74.73 - $90.69 $1.06 Million - $1.29 Million
-14,200 Reduced 30.28%
32,700 $2.45 Million
Q4 2020

Feb 12, 2021
BUY
$72.61 - $90.2 $653,490 - $811,800
9,000 Added 23.75%
46,900 $4.08 Million
Q3 2020

Nov 13, 2020
BUY
$71.87 - $131.03 $186,862 - $340,678
2,600 Added 7.37%
37,900 $2.88 Million
Q2 2020

Aug 13, 2020
BUY
$79.55 - $124.22 $501,165 - $782,586
6,300 Added 21.72%
35,300 $4.31 Million
Q1 2020

May 11, 2020
BUY
$71.37 - $96.85 $314,028 - $426,140
4,400 Added 17.89%
29,000 $2.39 Million
Q4 2019

Feb 12, 2020
BUY
$64.27 - $86.37 $160,675 - $215,925
2,500 Added 11.31%
24,600 $2.08 Million
Q3 2019

Nov 14, 2019
BUY
$67.4 - $85.11 $1.49 Million - $1.88 Million
22,100 New
22,100 $1.51 Million
Q2 2019

Aug 20, 2019
SELL
$80.35 - $93.9 $2.92 Million - $3.41 Million
-36,300 Closed
0 $0
Q1 2019

May 15, 2019
BUY
$84.2 - $98.62 $1.12 Million - $1.31 Million
13,300 Added 57.83%
36,300 $3.23 Million
Q4 2018

Feb 14, 2019
SELL
$80.14 - $106.07 $921,610 - $1.22 Million
-11,500 Reduced 33.33%
23,000 $1.92 Million
Q3 2018

Nov 14, 2018
BUY
$93.92 - $105.72 $1.19 Million - $1.34 Million
12,700 Added 58.26%
34,500 $3.35 Million
Q1 2018

May 15, 2018
BUY
$77.67 - $92.63 $481,554 - $574,306
6,200 Added 39.74%
21,800 $1.77 Million
Q4 2017

Feb 14, 2018
BUY
$80.76 - $95.13 $961,044 - $1.13 Million
11,900 Added 321.62%
15,600 $1.39 Million
Q3 2017

Nov 15, 2017
BUY
$80.6 - $94.95 $298,220 - $351,315
3,700
3,700 $344,000

Others Institutions Holding BMRN

# of Institutions
632
Shares Held
185M
Call Options Held
1.63M
Put Options Held
1.2M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $13.1B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email